19 research outputs found

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Xihuang Pill Induces Apoptosis of Human Glioblastoma U-87 MG Cells via Targeting ROS-Mediated Akt/mTOR/FOXO1 Pathway

    No full text
    Xihuang pill (XHP), a traditional Chinese herbal formula, has long been used as an effective agent against multiple tumors. The aim of this study is to evaluate the effects of XHP on the growth inhibition and apoptosis in glioblastoma U-87 MG cells. Gas chromatography-mass spectrometry (GC-MS) was performed for constituent analysis of XHP. Cell viability, cell cycle arrest, generation of reactive oxygen species (ROS), and apoptosis were measured by CCK-8 assay, PI/RNase staining, DCFH-DA assay, TUNEL assay, Annexin V-FITC/PI double staining, and JC-1 assay, respectively. The role of XHP in the regulation of Akt/mTOR/FOXO1 interaction was clarified by using Western Blotting (WB), immunofluorescence (IF), pharmacological inhibitor or antioxidant, and siRNA silencing. The results suggested that XHP could inhibit U-87 MG cells growth and arrest cells in S-phase cell cycle significantly and that the generation of ROS, collapse of mitochondrial membrane potential, enhancement of Bax/Bcl-xL ratio, and reduction of the precursor forms of caspase-9 and caspase-3 caused by XHP prompted that a ROS-mediated mitochondria-dependent apoptosis was possibly involved. Furthermore, XHP affected the Akt/mTOR/FOXO1 pathway via inhibiting the phosphorylation of Akt, mTOR, and FOXO1 and increasing both prototype and nuclear translocation of FOXO1. Inhibition of Akt, mTOR, and FOXO1 by specific inhibitors or siRNA could interpose the apoptotic induction. In conclusion, we demonstrate for the first time that XHP may regulate glioblastoma U-87 MG cell apoptosis via ROS-mediated Akt/mTOR/FOXO1 pathway

    Gridded pollen-based Holocene regional plant cover in temperate and northernsubtropical China suitable for climate modelling

    Get PDF
    We present the first gridded and temporally continuous quantitative pollen-based plant-cover reconstruction for temperate and northern subtropical China over the Holocene (11.7 ka to present) obtained by applying the Regional Estimates of VEgetation Abundance from Large Sites (REVEALS) model. The objective is to provide a dataset of pollen-based land cover for the last ca. 12 millennia that is suitable for palaeoclimate modelling and for the evaluation of simulated past vegetation cover from dynamic vegetation models and anthropogenic land-cover change (ALCC) scenarios. The REVEALS reconstruction was achieved using 94 selected pollen records from lakes and bogs at a 1 degrees x 1 degrees spatial scale and a temporal resolution of 500 years between 11.7 and 0.7 ka and in three recent time windows (0.7-0.35 ka, 0.35-0.1 ka, and 0.1 ka to present). The dataset includes REVEALS estimates of cover and their standard errors (SEs) for 27 plant taxa in 75 1 degrees x 1 degrees grid cells distributed within the study region. The 27 plant taxa were also grouped into 6 plant functional types and 3 land-cover types (coniferous trees CT, broadleaved trees BT, and C-3 herbs/open land (C3H/OL)), and their REVEALS estimates of cover and related SEs were calculated. We describe the protocol used for the selection of pollen records and the REVEALS application (with parameter settings) and explain the major rationales behind the protocol. As an illustration, we present, for eight selected time windows, gridded maps of the pollen-based REVEALS estimates of cover for the three land-cover types (CT, BT, and C3H/OL). We then discuss the reliability and limitations of the Chinese dataset of Holocene gridded REVEALS plant cover, and its current and potential uses. The dataset is available at the National Tibetan Plateau Data Center (TPDC; Li, 2022; )
    corecore